A committee of outside experts advising the Food and Drug Administration has convened this morning and is now publicly deliberating whether the agency should grant an Emergency Use Authorization for the COVID-19 vaccine developed by pharmaceutical giant Pfizer and its partner, German biotech firm BioNTech.
If the committee votes to grant an authorization—and the FDA agrees—the federal government’s Operation Warp Speed has said it will begin shipping vaccine allotments to states and jurisdictions within hours.
